Ilya Sipkin

Ilya Sipkin, MBA, serves as the Sr. Clinical Operations Finance Manager at Karyopharm Therapeutics Inc., overseeing a $100M+ Phase III clinical trial budget with a notable 98% forecast accuracy. Prior experience includes roles as a Clinical Operations Finance Manager at Karyopharm, where financial models improved forecast accuracy and accelerated patient enrollment in oncology trials, and as a Sr. Finance Global Business Partner at Seqirus, managing a $50M R&D budget. With a foundational background as a Financial Analyst at Raytheon BBN Technologies and Cassis Bakery Inc., Ilya Sipkin has demonstrated expertise in financial planning, cost reduction, and team training across various sectors. Educational qualifications include an MBA/MSF from Suffolk University and a Business Analytics Certificate from Cornell University, complemented by a Bachelor of Arts in Economics from the University of Massachusetts Amherst.